Editors' ChoiceMetabolism

IL-6: A hack to body fat and exercise?

See allHide authors and affiliations

Science Translational Medicine  23 Jan 2019:
Vol. 11, Issue 476, eaaw5316
DOI: 10.1126/scitranslmed.aaw5316


The IL-6 receptor antibody tocilizumab abolished the ability of exercise to reduce visceral fat and cholesterol levels in obese individuals.

View Full Text

Stay Connected to Science Translational Medicine